Login/Sign Up
₹345.5
(Inclusive of all Taxes)
₹255 with coupons & bank offers*
Get Free delivery (₹99) with
Sucrobind 500 mg Chewable Tablet is a medicine prescribed to control high phosphorus levels in the blood of adults with chronic kidney disease who are on dialysis. By keeping phosphorus levels within a healthy range, this medication helps prevent long-term bone and heart complications associated with kidney disease.
To work effectively, you must take Sucrobind 500 mg Chewable Tablet consistently with your meals or snacks as directed by your doctor. Along with taking this medicine, following a low-phosphorus diet recommended by your kidney specialist is essential for achieving the best results.
Some people may experience mild side effects, such as dark-colored stools or mild diarrhoea, which are typically harmless. However, you should consult your doctor immediately if you experience severe abdominal pain, persistent nausea, or signs of an allergic reaction.
Do not take this if you have iron overload disorders, such as hemochromatosis, or a history of severe stomach or intestinal disorders. Talk to your doctor before starting Sucrobind 500 mg Chewable Tablet if you have recently had stomach surgery or have active liver damage.
This medicine can interact with other oral medications, such as certain antibiotics or thyroid hormones, by reducing their absorption, so you may need to space them out. If you are pregnant, breastfeeding, or planning a pregnancy, talk to your doctor or pharmacist before using this medicine.
Sucrobind 500 mg Chewable Tablet helps lower high phosphate levels in people with chronic kidney disease undergoing dialysis. It may be used for:
Managing your phosphorus levels with Sucrobind 500 mg Chewable Tablet provides several key health benefits:
Caution
It is not recommended to drink alcohol while taking Sucrobind 500 mg Chewable Tablet because it may cause unpleasant side effects.
Caution
Please seek advice from a healthcare professional. There are no adequate and well-controlled studies on pregnant women. Your doctor will prescribe only if the benefits outweigh the risks.
Caution
Consult your healthcare professional as there is no substantial research yet on the use of Sucrobind 500 mg Chewable Tablet in breastfeeding/nursing mothers.
Caution
It is unknown whether Sucrobind 500 mg Chewable Tablet affects driving ability. Do not drive or operate machinery if you have any symptoms that impair your ability to concentrate or react.
Caution
Consult your doctor if you have liver problems. Your doctor will prescribe only if the benefits outweigh the risks.
Consult your doctor
Consult your doctor if you have kidney problems.
Caution
The safety and efficacy of Sucrobind 500 mg Chewable Tablet in children below 2years have not been established.
Consult your doctor
Limited information is available on the use of Sucrobind 500 mg Chewable Tablet in individuals with heart problems. Please consult your doctor. Your doctor will prescribe only if the benefits outweigh the risks.
Consult your doctor
Sucrobind 500 mg Chewable Tablet should be given to elderly patients only if prescribed by a doctor. If you have any concerns, please consult your doctor. Dose adjustment may be required based on their health condition.
Have a query?
The time required for Sucrobind 500 mg Chewable Tablet to start to work: Sucrobind 500 mg Chewable Tablet ideally shows its action within few hours after administration.
The time for which the effects of Sucrobind 500 mg Chewable Tablet last: The effect of Sucrobind 500 mg Chewable Tablet lasts for 4 to 6 hours.
Login/Sign Up
No clinically significant food interactions are known with Sucrobind 500 mg Chewable Tablet when used as directed.
Login/Sign Up
Disclaimer
